MONOPAR THERAPEUTICS INC.
Ownership & governance
Executives 5Directors 6Avg age 60Avg tenure 7.2y
CR
Chandler Robinson
Chief Executive Officer
Age 42Since 2014-11-30Profile →
+10
Executives5
Board of directors6
CR
Chandler Robinson→
Director/Board Member
Age 42Since 2014-11-30
CS
Christopher Starr→
Chairman
Age 73Since 2014-11-30
RA
Raymond Anderson→
Director/Board Member
Age 84Since 2017-03-31
KT
Kim Tsuchimoto→
Director/Board Member
Age 63Since 2023-02-28
LT
Lavina Talukdar→
Director/Board Member
—Since 2025-02-20
NS
Nicole Sweeny→
Director/Board Member
Age 51—
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Janus Henderson Investors US LLC | 19.67 % | 1,317,410 |
| RA Capital Management LP | 9.96 % | 667,207 |
| Gem Pharmaceuticals LLC | 8.473 % | 567,580 |
| ASTRAZENECA PLC | 7.802 % | 522,667 |
| Saturn V Capital Management LP | 5.159 % | 345,626 |
Catalog · 2026-07-09
Registry officers11
| Name | Role | Since | Shares |
|---|---|---|---|
| Andrew Cittadine | Chief Operating Officer | 2021-05-31 | - |
| Chandler Robinson | Chief Executive Officer | 2014-11-30 | - |
| Christopher Starr | Chairman | 2014-11-30 | - |
| Holli Carlson | Chief Tech/Sci/R&D Officer | — | - |
| Patrice Rioux | Chief Tech/Sci/R&D Officer | 2016-11-30 | - |
| Quan Anh Vu | Director of Finance/CFO | 2025-03-02 | - |
| Chandler Robinson | Director/Board Member | 2014-11-30 | - |
| Kim Tsuchimoto | Director/Board Member | 2023-02-28 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 129.92Range 119–145Analysts 12
119Mean 129.92145
- Strong buy 4
- Buy 7
- Hold 1
Broker actions40 of 55
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | 145 | 2026-09-11 |
| Barclays | Maintained | Overweight | 128 | 2026-08-13 |
| Cantor Fitzgerald | Downgrade | Neutral | 119 | 2026-08-13 |
| BTIG | Maintained | Buy | 133 | 2026-08-12 |
| HC Wainwright & Co. | Maintained | Buy | 125 | 2026-07-22 |
| BTIG | Maintained | Buy | 117 | 2026-06-30 |
| HC Wainwright & Co. | Reiterated | Buy | 105 | 2026-06-29 |
| Chardan Capital | Maintained | Buy | 100 | 2026-03-30 |
| BTIG | Reiterated | Buy | 104 | 2026-02-23 |
| BTIG | Reiterated | Buy | 104 | 2026-02-02 |
| Chardan Capital | Maintained | Buy | 100 | 2026-01-29 |
| BTIG | Reiterated | Buy | 104 | 2026-01-14 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.